PIK3CA and neoplasm: There was no correlation between the presence of BRAF and PIK3CA mutations with the patients' gender, age (>70 years old versus ≤70 years old), stage at diagnosis, tumour location, mucinous status, PTEN loss and AREG expression (in both cases all p-values >0.05).